secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tempest Therapeutics, Inc. (TPST)
CIK:        0001544227
Form:       8-K
Filed at:   2026-05-22T21:28:16+00:00
Accession:  0001193125-26-237207
Event type: regulatory
Sentiment:  negative
Materiality: 0.90
Item codes: 3.01, 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Tempest Therapeutics warned by Nasdaq for low equity and board independence; two directors resign
--------------------------------------------------------------------------------

- Stockholders' equity of $822k vs Nasdaq's $2.5M minimum; 45 days to submit compliance plan by July 6, 2026.
- Directors Michael Raab and Christine Pellizzari resigned, causing non-compliance with majority independence and committee rules.
- Company not eligible for standard cure period due to multiple vacancies; must submit plan for board compliance within 45 days.
- Both deficiencies have no immediate listing effect but risk delisting if plans rejected or compliance not achieved.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1544227/000119312526237207/0001193125-26-237207-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1544227/000119312526237207/d131489d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-237207

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer